Tuesday, 4 July 2017

Quercetin kháng Bel-7402

[HTML] … effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells …

Quercetin kháng Bel-7402

From Wikipedia, the free encyclopedia
Quercetin
Skeletal formula of quercetin
Ball-and-stick model of the quercetin molecule
Names
Pronunciation/ˈkwɜːrstn/
IUPAC name
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
Other names
5,7,3′,4′-flavon-3-ol, Sophoretin, Meletin, Quercetine, Xanthaurine, Quercetol, Quercitin, Quertine, Flavin meletin
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
DrugBank
ECHA InfoCard100.003.807
KEGG
PubChem CID
UNII
Properties
C15H10O7
Molar mass302.236 g/mol
Appearanceyellow crystalline powder[1]
Density1.799 g/cm3
Melting point316 °C (601 °F; 589 K)
Practically insoluble in water; soluble in aqueous alkaline solutions[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
 verify (what is Yes ?)
Infobox references
UV visible spectrum of quercetin, with lambda max at 369 nm.
Quercetin is a plant polyphenol from the flavonoid group, found in many fruits, vegetables, leaves, and grains. It can be used as an ingredient in supplements, beverages, or foods.

Health effects[edit]

While quercetin supplements have been promoted for prevention and treatment of cancer, "there is no reliable clinical evidence that quercetin can prevent or treat cancer in humans".[2] Also, there is no conclusive evidence that consuming foods rich in quercetin reduces the risk of cancer or any other disease.[3]
Quercetin supplements have also been promoted for the treatment of a wide spectrum of other diseases.[4] However, the European Food Safety Authority evaluated possible health claims associated with consumption of quercetin, and found that no cause-and-effect relationship has been established for any physiological effect in human health or diseases.[5]

Drug interactions[edit]

Quercetin is contraindicated with some antibiotics; it may interact with fluoroquinolones (a class of antibiotics), as quercetin competitively binds to bacterial DNA gyrase. Whether this inhibits or enhances the effect of fluoroquinolones is not certain.[6]
As paclitaxel is metabolized primarily by CYP2C8, its bioavailability may be increased unpredictably by quercetin, potentially leading to harmful side effects.[7][8]

Occurrence[edit]

Quercetin is a flavonoid widely distributed in nature. The name has been used since 1857, and is derived from quercetum(oak forest), after Quercus.[9][10] It is a naturally occurring polar auxin transport inhibitor.[11]
Quercetin is one of the most abundant dietary flavonoids with an average daily consumption of 25–50 mgs.[12]
Foods containing quercetinQuercetin (mg/100g of edible portion)
capers, raw234[13]
capers, canned173[13]
lovage170[13]
dock like sorrel86[13]
radish leaves70[13]
carob fiber58[13]
dill55[14] (48-110)[15]
cilantro53[13]
Hungarian wax pepper51[13]
fennel leaves48.8[13]
onion, red32[16]
radicchio31.5[13]
watercress30[16]
buckwheat23[17]
kale23[16]
chokeberry19[16]
cranberry15[16]
lingonberry13[16]
plums, black12[16]
cow peas11[16]
sweet potato10[16]
blueberry, cultivated8[16]
sea buckthorn berry8[16]
rowanberry7[16]
crowberry5[16]
prickly pear cactus fruits5[16]
applesRed Delicious4[16]
broccoli3[16]
bilberry3[16]
tea, black or green Camellia sinensis2[16]
red kidney beans, raw (powdered)0.0603 +/- 0.0307[18]
In red onions, higher concentrations of quercetin occur in the outermost rings and in the part closest to the root, the latter being the part of the plant with the highest concentration.[19] One study found that organically grown tomatoes had 79% more quercetin than non-organically grown fruit.[20] Quercetin is present in various kinds of honey from different plant sources.[21]

Biosynthesis[edit]

In plants, phenylalanine is converted to 4-coumaroyl-CoA in a series of steps known as the general phenylpropanoid pathway using phenylalanine ammonia-lyasecinnamate-4-hydroxylase, and 4-coumaroyl-CoA-ligase.[22] One molecule of 4-coumaroyl-CoA is added to three molecules of malonyl-CoA to form tetrahydroxychalcone using 7,2′-dihydroxy-4′-methoxyisoflavanol synthase. Tetrahydroxychalcone is then converted into naringenin using chalcone isomerase.
Naringenin is converted into eriodictyol using flavanoid 3′-hydroxylase. Eriodictyol is then converted into dihydroquercetin with flavanone 3-hydroxylase, which is then converted into quercetin using flavonol synthase.[22]

Glycosides[edit]

3-O-Glycosides of quercetin
Quercetin is the aglycone form of a number of other flavonoid glycosides, such as rutin and quercitrin, found in citrus fruit, buckwheat and onions. Quercetin forms the glycosides quercitrin and rutin together with rhamnose and rutinose, respectively. Likewise guaijaverin is the 3-O-arabinosidehyperoside is the 3-O-galactosideisoquercitin is the 3-O-glucoside and spiraeoside is the 4′-O-glucoside. CTN-986 is a quercetin derivative found in cottonseeds and cottonseed oil. Miquelianin is the quercetin 3-O-β-D-glucuronopyranoside.[23]

Rutin degradation pathway[edit]

The enzyme quercitrinase can be found in Aspergillus flavus.[24] This enzyme hydrolyzes the glycoside quercitrin to release quercetin and L-rhamnose. It is an enzyme in the rutin catabolic pathway[25]

Pharmacology[edit]

Pharmacokinetics[edit]

The bioavailability of quercetin in humans is low and highly variable (0-50%), and is rapidly cleared with an elimination half-life of 1–2 hours after ingesting quercetin foods or supplements.[26] Following dietary ingestion, quercetin undergoes rapid and extensive metabolism that makes the biological effects presumed from in vitrostudies unlikely to apply in vivo.[27][28]

Metabolism[edit]

In rats, quercetin did not undergo any significant phase I metabolism.[29] In contrast, quercetin did undergo extensive phase II (conjugation) to produce metabolites that are more polar than the parent substance and hence are more rapidly excreted from the body. The meta-hydroxyl group of catechol is methylated by catechol-O-methyltransferase. Four of the five hydroxyl groups of quercetin are glucuronidated by UDP-glucuronosyltransferase. The exception is the 5-hydroxyl group of the flavonoid ring which generally does not undergo glucuronidation. The major metabolites of orally absorbed quercetin are quercetin-3-glucuronide3'-methylquercetin-3-glucuronide, and quercetin-3'-sulfate.[29][30]

In vitro pharmacology[edit]

Quercetin has been reported to inhibit the oxidation of other molecules and hence is classified as an antioxidant.[27][30] Quercetin contains a polyphenolic chemical substructure that stops oxidation by acting as a scavenger of free radicals that are responsible for oxidative chain reactions.[31]
Quercetin also activates or inhibits the activities of a number of proteins.[32] For example, quercetin is a non-specific protein kinase enzyme inhibitor.[27][30] Quercetin has also been reported to have estrogenic (female sex hormone like) activities by activating estrogen receptors. Quercetin activates both estrogen receptor alpha (ERα) and beta (ERβ)[33] with binding IC50s of 1015 nM and 113 nM respectively. Hence quercetin is somewhat ERβ selective (9 fold) and is roughly two to three orders of magnitude less potent than the endogenous estrogenic hormone 17β-estradiol.[34][35] In human breast cancer cell lines, quercetin has also been found to act as an agonist of the G protein-coupled estrogen receptor (GPER).[36][37]

Clinical research[edit]

Although quercetin is under basic and early-stage clinical research for a variety of disease conditions,[38][39] there is insufficient evidence on whether quercetin promotes DNA repair in humans.[5] Claims about the role of quercetin in liver and kidney system function, mental performance or cardiovascular health in the human body are insufficiently defined to draw any conclusions.[5] The US FDA has issued warning letters to emphasize that quercetin is not a defined nutrient nor an antioxidant, cannot be assigned a dietary content level, and is not regulated as a drug to treat any human disease.[40]

Perifosine kháng Bel-7402

Perifosine induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cell lines by blockade of Akt phosphorylation

Perifosine kháng Bel-7402

From Wikipedia, the free encyclopedia
Perifosine
Skeletal formula of perifosine
Space-filling model of the perifosine zwitterion
Names
IUPAC name
1,1-Dimethylpiperidinium-4-yl octadecyl phosphate
Other names
D 21266; KRX 0401
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard100.217.789
PubChem CID
UNII
Properties
C25H52NO4P
Molar mass461.67 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Perifosine (also KRX-0401) is a drug candidate being developed for a variety of cancer indications. It is an alkyl-phospholipid[1] structurally related to miltefosine. It acts as an Akt inhibitor and a PI3K inhibitor. It was being developed by Keryx Biopharmaceuticals who have licensed it from Æterna Zentaris Inc.[2]
In 2010 perifosine has reached phase II.[3] In one phase II trial for metastatic colon cancer perifosine doubled time to progression.[2]
It has orphan drug status in the U.S. for the treatment of multiple myeloma and neuroblastoma, and for multiple myeloma in the EU.[4]
In 2011 it was in a phase III trial for colorectal cancer,[5] and another for multiple myeloma.[4][6] On April 2, 2012, it was announced that perifosine failed its phase III clinical trial for treatment of colon cancer.[7] Detailed results were released in June 2012.[8] On March 11, 2013 Aeterna Zentaris announced the discontinuing of Phase 3 clinical trial of perifosine for the treatment of relapsed and refractory multiple myeloma http://www.aezsinc.com/en/page.php?p=60&q=550.

Geldanamycin kháng Bel-7402

Synergistic effects of geldanamycin and antitumor drugs.

Geldanamycin kháng Bel-7402

From Wikipedia, the free encyclopedia
Geldanamycin
Geldanamycin.svg
Names
IUPAC name
(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
Identifiers
3D model (JSmol)
ChemSpider
DrugBank
PubChem CID
Properties
C29H40N2O9
Molar mass560.64 g/mol
AppearanceGold-yellow fine crystalline powder
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Yes verify (what is Yes ?)
Infobox references
Geldanamycin is a 1,4-benzoquinone ansamycin antitumor antibiotic that inhibits the function of Hsp90 (Heat Shock Protein 90) by binding to the unusual ADP/ATP-binding pocket of the protein.[1] HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, apoptosisangiogenesis and oncogenesis.
Hsp90-geldanamycin complex. PDB 1yet[2]
Geldanamycin induces the degradation of proteins that are mutated in tumor cells such as v-SrcBcr-Abl and p53preferentially over their normal cellular counterparts. This effect is mediated via HSP90. Despite its potent antitumor potential, geldanamycin presents several major drawbacks as a drug candidate such as hepatotoxicity, further, Jilani et al. reported that geldanamycin induces the apoptosis of erythrocytes under physiological concentrations.[3] These side effects have led to the development of geldanamycin analogues, in particular analogues containing a derivatisation at the 17 position:

Biosynthesis[edit]

Geldanamycin was originally discovered in the organism Streptomyces hygroscopicus.[4] It is a macrocyclic polyketide that is synthesized by a Type I polyketide synthase. The genes gelA, gelB, and gelC encode for the polyketide synthase. The PKS is first loaded with 3-amino-5-hydroxybenzoic acid (AHBA). It then utilizes malonyl-CoAmethylmalonyl-CoA, and methoxymalonyl-CoA to synthesize the precursor molecule Progeldanamycin.[5] This precursor is subjected to several enzymatic and non-enzymatic tailoring steps to produce the active molecule Geldanamycin, which include hydroxylation, o-methylation, carbamoylation, and oxidation.[6]